BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rimassa L, Reig M, Abbadessa G, Peck-Radosavljevic M, Harris W, Zagonel V, Pastorelli D, Rota Caremoli E, Porta C, Damjanov N, Patel H, Daniele B, Lamar M, Schwartz B, Goldberg T, Santoro A, Bruix J. Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma. World J Gastroenterol 2017; 23(13): 2448-2452 [PMID: 28428725 DOI: 10.3748/wjg.v23.i13.2448]
URL: https://www.wjgnet.com/1007-9327/full/v23/i13/2448.htm
Number Citing Articles
1
Francesco Tovoli, Stefania De Lorenzo, Maria Aurelia Barbera, Ingrid Garajova, Giorgio Frega, Andrea Palloni, Maria Abbondanza Pantaleo, Guido Biasco, Giovanni Brandi. Postsorafenib systemic treatments for hepatocellular carcinoma: questions and opportunities after the regorafenib trialFuture Oncology 2017; 13(21): 1893 doi: 10.2217/fon-2017-0166
2
Jordi Bruix, Leonardo G. da Fonseca, María Reig. Insights into the success and failure of systemic therapy for hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology 2019; 16(10): 617 doi: 10.1038/s41575-019-0179-x
3
Sebastião N. Martins-Filho, Venâncio Avancini Ferreira Alves. The strengths and weaknesses of gross and histopathological evaluation in hepatocellular carcinoma: a brief reviewSurgical and Experimental Pathology 2019; 2(1) doi: 10.1186/s42047-019-0047-6
4
Weihao Kong, Jun Zheng, Liang Chen, Xiaomin Zuo, Hengyi Wang, Xingyu Wang, Jia Yao, Wei Chen. Mean Corpuscular Hemoglobin Concentration Correlates with Prognosis of Resected Hepatocellular CarcinomaBiomarkers in Medicine 2020; 14(4): 259 doi: 10.2217/bmm-2019-0224
5
Francesco Paolo Russo, Angela Imondi, Erica Nicola Lynch, Fabio Farinati. When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A reviewDigestive and Liver Disease 2018; 50(7): 640 doi: 10.1016/j.dld.2018.03.014
6
Nicola Personeni, Tiziana Pressiani, Lorenza Rimassa. Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinomaHealth Science Reports 2020; 3(1) doi: 10.1002/hsr2.147
7
Chiara C. Volpi, Ambra V. Gualeni, Filippo Pietrantonio, Emanuela Vaccher, Antonino Carbone, Annunziata Gloghini. Bright-fieldin situhybridization detects gene alterations and viral infections useful for personalized management of cancer patientsExpert Review of Molecular Diagnostics 2018; 18(3): 259 doi: 10.1080/14737159.2018.1440210
8
Amit G. Singal, Yujin Hoshida, David J. Pinato, Jorge Marrero, Jean-Charles Nault, Valerie Paradis, Nabihah Tayob, Morris Sherman, Young Suk Lim, Ziding Feng, Anna S. Lok, Jo Ann Rinaudo, Sudhir Srivastava, Josep M. Llovet, Augusto Villanueva. International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular CarcinomaGastroenterology 2021; 160(7): 2572 doi: 10.1053/j.gastro.2021.01.233
9
María Reig, Leonardo Gomes da Fonseca, Sandrine Faivre. New trials and results in systemic treatment of HCCJournal of Hepatology 2018; 69(2): 525 doi: 10.1016/j.jhep.2018.03.028